Patent application number | Description | Published |
20100267673 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS - Tocopheryl succinate derivatives according to formula I: | 10-21-2010 |
20100267820 | ANTIADHESION AGENTS - Vitamin E succinate derivatives according to formula I: | 10-21-2010 |
20120108823 | ANTI-FRANCISELLA AGENTS - A series of celecoxib derivatives defined by Formula I: | 05-03-2012 |
20120136063 | FTY720-DERIVED ANTICANCER AGENTS - A number of FTY720-derived compounds with antitumor activity are described. These compounds include the compounds of formula I: | 05-31-2012 |
20120142702 | INTEGRIN-LINKED KINASE INHIBITORS - A number of compounds and use of the compounds in a method for treating or preventing cancer in a subject by administering to the subject a pharmaceutical composition including a compound of formula I or a pharmaceutically acceptable salt thereof are described. | 06-07-2012 |
20130289004 | ANTI-STAPHYLOCOCCAL CELECOXIB DERIVATIVES - A method of treating infection by | 10-31-2013 |
20140031388 | AKT INACTIVATION BY TOCOPHERYL DERIVATIVES - Anticancer compounds according to formula I are described herein. | 01-30-2014 |
20150051255 | GLUCOSE TRANSPORTER INHIBITORS - Thiazolidinedione compounds and pharmaceutically acceptable salts thereof are described. The compounds can be used in methods of treating cancer in a subject by administering to the subject a therapeutically effective amount of the compound. The compounds can also be used in methods of inhibiting glucose uptake in a cell by contacting the cell with the compound. | 02-19-2015 |